Endo ($ENDP) hasn't quite wrapped up its $8 billion deal for generics maker Par Pharmaceutical, recently agreeing to a loan package to speed things along. Now, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback